R. Idilman

Efficacy of tenofovir alafenamide in patients with chronic hepatitis B undergoing chronic hemodialysis and kidney transplantation: A real-world data study

Background and Aim: This study evaluated the efficacy and safety of tenofovir alafenamide (TAF) in chronic hepatitis B virus-infected patients undergoing chronic hemodialysis and kidney transplant recipients. Materials and Methods: Between January 2019 and January 2023, patients receiving TAF who were undergoing chron...

Hospitalisation in cirrhosis is linked to distinct gut microbiome structural and functional profiles: a multinational metagenomic study.

BACKGROUND Hospitalisations represent major clinical events in cirrhosis, yet prediction based on clinical variables alone remains limited. OBJECTIVE Given the role of the gut microbiome in disease progression, we evaluated whether gut metagenomic profiles are associated with 90-day hospitalisation and provide additi...

Anthropometric measurements, nutritional status, and diet quality of cirrhosis patients: Comparison of two etiologies

Background and Aim: This study aimed to compare anthropometric measurements, nutritional status, and diet quality between two etiologic groups of patients with cirrhosis. Materials and Methods: This study was conducted with 60 patients (30 women–30 men) with non-alcoholic fatty liver disease (NAFLD) and hepatitis B-C...

in MASLD: Findings from a Turkish cohort